Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Pharmacology, clinical efficacy and safety of olopatadine hydrochloride.

Expert review of clinical immunology

Lichtenstein SJ, Abelson MB.
PMID: 20476906
Expert Rev Clin Immunol. 2006 May;2(3):341-51. doi: 10.1586/1744666X.2.3.341.

Olopatadine is a multimechanism anti-allergic agent that inhibits H(1) receptor activation and stabilizes mast cell membranes, blocking the release of allergic and inflammatory mediators. Studies in human conjunctival mast cells clearly demonstrate, in the relevant tissue and species, olopatadine's...

Cite
Lichtenstein SJ, Abelson MB. Pharmacology, clinical efficacy and safety of olopatadine hydrochloride. Expert Rev Clin Immunol. 2006;2(3):341-51doi: 10.1586/1744666X.2.3.341.
Lichtenstein, S. J., & Abelson, M. B. (2006). Pharmacology, clinical efficacy and safety of olopatadine hydrochloride. Expert review of clinical immunology, 2(3), 341-51. https://doi.org/10.1586/1744666X.2.3.341
Lichtenstein, Steven J, and Abelson, Mark B. "Pharmacology, clinical efficacy and safety of olopatadine hydrochloride." Expert review of clinical immunology vol. 2,3 (2006): 341-51. doi: https://doi.org/10.1586/1744666X.2.3.341
Lichtenstein SJ, Abelson MB. Pharmacology, clinical efficacy and safety of olopatadine hydrochloride. Expert Rev Clin Immunol. 2006 May;2(3):341-51. doi: 10.1586/1744666X.2.3.341. PMID: 20476906.
Copy Download .nbib Format: NLM
Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter-3 in immunoglobulin G4-related autoimmune hepatitis.

Hepatology research : the official journal of the Japan Society of Hepatology

Araki T, Arinaga-Hino T, Koga H, Akiba J, Ide T, Okabe Y, Kuwahara R, Amano K, Yasumoto M, Kawaguchi T, Sano T, Kondou R, Kurata S, Mitsuyama K, Torimura T.
PMID: 29737040
Hepatol Res. 2018 Oct;48(11):937-944. doi: 10.1111/hepr.13188. Epub 2018 Jun 04.

Immunoglobulin (Ig)G4-related autoimmune hepatitis (AIH) is a recently proposed subtype that responds well to steroid treatment; however, its pathogenesis remains unclear. We report here a 65-year-old Japanese woman with skin itching and lip swelling. She had liver injury with...

Cite
Araki T, Arinaga-Hino T, Koga H, et al. Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter-3 in immunoglobulin G4-related autoimmune hepatitis. Hepatol Res. 2018;48(11):937-944doi: 10.1111/hepr.13188.
Araki, T., Arinaga-Hino, T., Koga, H., Akiba, J., Ide, T., Okabe, Y., Kuwahara, R., Amano, K., Yasumoto, M., Kawaguchi, T., Sano, T., Kondou, R., Kurata, S., Mitsuyama, K., & Torimura, T. (2018). Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter-3 in immunoglobulin G4-related autoimmune hepatitis. Hepatology research : the official journal of the Japan Society of Hepatology, 48(11), 937-944. https://doi.org/10.1111/hepr.13188
Araki, Toshihiro, et al. "Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter-3 in immunoglobulin G4-related autoimmune hepatitis." Hepatology research : the official journal of the Japan Society of Hepatology vol. 48,11 (2018): 937-944. doi: https://doi.org/10.1111/hepr.13188
Araki T, Arinaga-Hino T, Koga H, Akiba J, Ide T, Okabe Y, Kuwahara R, Amano K, Yasumoto M, Kawaguchi T, Sano T, Kondou R, Kurata S, Mitsuyama K, Torimura T. Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter-3 in immunoglobulin G4-related autoimmune hepatitis. Hepatol Res. 2018 Oct;48(11):937-944. doi: 10.1111/hepr.13188. Epub 2018 Jun 04. PMID: 29737040.
Copy Download .nbib Format: NLM
Therapeutic Effect of Glucosamine on an Atopic Dermatitis Animal Model.

Annals of dermatology

Yoon HS, Byun JW, Shin J, Kim YH, Choi GS.
PMID: 33911646
Ann Dermatol. 2019 Oct;31(5):538-544. doi: 10.5021/ad.2019.31.5.538. Epub 2019 Aug 30.

BACKGROUND: Recent studies have reported that glucosamine (GlcN) showed therapeutic effects in allergic diseases such as asthma and rhinitis, and its mechanisms include the suppression of T helper type 2 immune responses and the nuclear factor-κB pathway.OBJECTIVE: We aimed...

Cite
Yoon HS, Byun JW, Shin J, et al. Therapeutic Effect of Glucosamine on an Atopic Dermatitis Animal Model. Ann Dermatol. 2019;31(5):538-544doi: 10.5021/ad.2019.31.5.538.
Yoon, H. S., Byun, J. W., Shin, J., Kim, Y. H., & Choi, G. S. (2019). Therapeutic Effect of Glucosamine on an Atopic Dermatitis Animal Model. Annals of dermatology, 31(5), 538-544. https://doi.org/10.5021/ad.2019.31.5.538
Yoon, Hee Seong, et al. "Therapeutic Effect of Glucosamine on an Atopic Dermatitis Animal Model." Annals of dermatology vol. 31,5 (2019): 538-544. doi: https://doi.org/10.5021/ad.2019.31.5.538
Yoon HS, Byun JW, Shin J, Kim YH, Choi GS. Therapeutic Effect of Glucosamine on an Atopic Dermatitis Animal Model. Ann Dermatol. 2019 Oct;31(5):538-544. doi: 10.5021/ad.2019.31.5.538. Epub 2019 Aug 30. PMID: 33911646; PMCID: PMC7992559.
Copy Download .nbib Format: NLM
Inhibition of Allergic Response by Intranasal Selective NF-κB Decoy Oligodeoxynucleotides in a Murine Model of Allergic Rhinitis.

Allergy, asthma & immunology research

Wee JH, Zhang YL, Rhee CS, Kim DY.
PMID: 27826963
Allergy Asthma Immunol Res. 2017 Jan;9(1):61-69. doi: 10.4168/aair.2017.9.1.61.

PURPOSE: It remains unknown whether local inhibition of Nuclear factor-kappa B (NF-κB) could have therapeutic value in the treatment of allergic rhinitis (AR). This study aimed to evaluate the effect of selective NF-κB inhibition using NF-κB decoy oligodeoxynucleotides (ODNs)...

Cite
Wee JH, Zhang YL, Rhee CS, et al. Inhibition of Allergic Response by Intranasal Selective NF-κB Decoy Oligodeoxynucleotides in a Murine Model of Allergic Rhinitis. Allergy Asthma Immunol Res. 2017;9(1):61-69doi: 10.4168/aair.2017.9.1.61.
Wee, J. H., Zhang, Y. L., Rhee, C. S., & Kim, D. Y. (2017). Inhibition of Allergic Response by Intranasal Selective NF-κB Decoy Oligodeoxynucleotides in a Murine Model of Allergic Rhinitis. Allergy, asthma & immunology research, 9(1), 61-69. https://doi.org/10.4168/aair.2017.9.1.61
Wee, Jee Hye, et al. "Inhibition of Allergic Response by Intranasal Selective NF-κB Decoy Oligodeoxynucleotides in a Murine Model of Allergic Rhinitis." Allergy, asthma & immunology research vol. 9,1 (2017): 61-69. doi: https://doi.org/10.4168/aair.2017.9.1.61
Wee JH, Zhang YL, Rhee CS, Kim DY. Inhibition of Allergic Response by Intranasal Selective NF-κB Decoy Oligodeoxynucleotides in a Murine Model of Allergic Rhinitis. Allergy Asthma Immunol Res. 2017 Jan;9(1):61-69. doi: 10.4168/aair.2017.9.1.61. PMID: 27826963; PMCID: PMC5102837.
Copy Download .nbib Format: NLM
Emerging therapeutic strategies for eosinophilic esophagitis.

Current treatment options in gastroenterology

Lucendo AJ, Molina-Infante J.
PMID: 24370990
Curr Treat Options Gastroenterol. 2014 Mar;12(1):1-17. doi: 10.1007/s11938-013-0001-8.

OPINION STATEMENT: Eosinophilic esophagitis (EoE) is recognized as an increasingly common cause of chronic and recurrent esophageal symptoms that significantly impact quality of life and may occasionally result in severe complications in both pediatric and adult patients. The disease...

Cite
Lucendo AJ, Molina-Infante J. Emerging therapeutic strategies for eosinophilic esophagitis. Curr Treat Options Gastroenterol. 2014;12(1):1-17doi: 10.1007/s11938-013-0001-8.
Lucendo, A. J., & Molina-Infante, J. (2014). Emerging therapeutic strategies for eosinophilic esophagitis. Current treatment options in gastroenterology, 12(1), 1-17. https://doi.org/10.1007/s11938-013-0001-8
Lucendo, Alfredo J, and Molina-Infante, Javier. "Emerging therapeutic strategies for eosinophilic esophagitis." Current treatment options in gastroenterology vol. 12,1 (2014): 1-17. doi: https://doi.org/10.1007/s11938-013-0001-8
Lucendo AJ, Molina-Infante J. Emerging therapeutic strategies for eosinophilic esophagitis. Curr Treat Options Gastroenterol. 2014 Mar;12(1):1-17. doi: 10.1007/s11938-013-0001-8. PMID: 24370990.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries